Biogen Idec International Neuroscience GmbH and University of Zurich File Patent Application for Anti-alpha Synuclein Binding Molecules
The abstract of the patent published by the Controller General of Patents, Designs & Trade Marks states: "Provided is anti-human a synuclein specific binding molecules e.g. antibodies or antiben binding fragments variants or derivatives thereof as methods related thereto.
Saved in:
| Published in: | Indian Patents News |
|---|---|
| Format: | Newsletter |
| Language: | English |
| Published: |
New Delhi
Athena Information Solutions Pvt. Ltd
17.05.2016
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!